An investigational GLP-1 pill from Structure Therapeutics led to substantial weight loss, but patients also had high rates of ...
Structure Therapeutics said on Monday that its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback